• ABOUT
    • About Us
    • Executive Leadership
    • Professional Management
    • Board of Directors
    • Scientific Advisory Board
  • PIPELINE
    • PLEX PLATFORM PIPELINE
    • PREVENTION of SSIs
    • D-PLEX100 EFFICACY
    • About D-PLEX
    • CLINICAL TRIALS
  • Technology
    • PLEX Platform
    • CANCER RESEARCH PROGRAM
    • PAIN RESEARCH PROGRAM
    • Partnership
    • MANUFACTURING FACILITY
    • Scientific Publications
  • Investors
    • PRESS RELEASES
    • EVENTS & PRESENTATIONS
    • FINANCIAL INFORMATION
    • CORPORATE GOVERNANCE
    • ANALYST COVERAGE
    • SHARE INFORMATION
    • SHAREHOLDER SERVICES
  • Contact
    • Contact Us
    • Careers

Site map

HOME
TECHNOLOGY
  • PLEX Platform
  • Partnership
  • Publications
PIPELINE
  • Overview
  • About D-PLEX
  • D-PLEX1000
  • D-PLEX500
  • Research Programs
  • Ongoing Clinical Trials
NEWS & EVENTS
  • News
  • Events
ABOUT
  • About Us
  • Executive Leadership
  • Professional Management
  • Board of Directors
  • Scientific Advisory Board
CONTACT
  • Contact Us
  • Careers

PolyPid’s PLEX targeted drug delivery platform enables a localized, controlled release and prolonged medication solutions for better patient outcome.

PolyPid Ltd. (Headquarters)

18 Hasivim Street, P.O Box 7126
Petach Tikva, Israel 4917002

Phone: +972-74-719-5700

PolyPid Inc.

47 Maple St. Suite # 302A
Summit NJ 07901
Phone: (908) 858-5995

General Information: info@polypid.com

Business Development: BD@polypid.com

  • HOME
  • ABOUT
  • PIPELINE
  • TECHNOLOGY
  • INVESTORS
  • CONTACT
  • ABOUT US
  • PLEX PLATFORM PIPELINE
  • ABOUT D-PLEX
  • CLINICAL TRIALS
  • PLEX PLATFORM
  • CANCER RESEARCH PROGRAM
  • MANUFACTURING FACILITY
  • PARTNERSHIP
© All rights reserved to POLYPID 2015
  • Privacy Policy​
  • CCPA Notice​
  • Site map
UX, UI, Web Development
We use cookies for functional and analytic and advertising purposes. Review our Cookie Policy to learn more, including how to adjust your cookies setting.I Agree